Get started
Author

Maurizio Cantore

Observed names: Cantore, Maurizio, M Cantore, M. Cantore, MAURIZIO CANTORE
Observed institutions: University of Siena, University of Verona, University of Milan, Mario Negri Institute for Pharmacological Research, University of L'Aquila, Hôpital Beaujon, Institut Gustave Roussy, Luigi Sacco Hospital, Azienda Unità Sanitaria Locale 11 di Empoli, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, San Salvatore Hospital, Ospedale San Carlo, Hôpital Saint-Antoine, Istituto Oncologico Veneto, Ospedali Riuniti Marche Nord, Istituto di Ematologia di Bologna, European School of Oncology, IRCCS Ospedale San Raffaele, Ospedale San Giuseppe, Fondazione IRCCS Istituto Nazionale dei Tumori, Azienda Ospedaliera Carlo Poma, Hôpital Tenon, Regione Toscana, Azienda USL Toscana Nord Ovest, Ospedale P. Pederzoli – Casa di Cura Privata S.p.a., European Institute of Oncology, University of Bologna
ORCID: 0000-0002-3360-499X
Observed ORCID: 0000-0002-3360-499X
OpenAlex ID: A5043872623
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer
2014 · E. Bajetta, I. Floriani, et al. · Annals of Oncology · 92
PDF
Pet therapy effects on oncological day hospital patients undergoing chemotherapy treatment.
2007 · Massimo Orlandi, Karina Trangeled, et al. · PubMed · 84
Combined modality treatment for patients with locally advanced pancreatic adenocarcinoma
2012 · M Cantore, R Girelli, et al. · British journal of surgery · 78
Combined Irinotecan and Oxaliplatin in Patients with Advanced Pre-Treated Pancreatic Cancer
2004 · M. Cantore, C. Rabbi, et al. · Oncology · 77
TERT gene harbors multiple variants associated with pancreatic cancer susceptibility
2015 · Daniele Campa, Cosmeri Rizzato, et al. · International Journal of Cancer · 76
Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5‐fluorouracil in patients with unresectable biliary tract tumors
2005 · Maurizio Cantore, Andrea Mambrini, et al. · Cancer · 75
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study
2014 · R. Buzzoni, S. Pusceddu, et al. · Annals of Oncology · 69
PDF
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial
2018 · Alberto Sobrero, Sara Lonardi, et al. · Journal of Clinical Oncology · 68
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium
2012 · Daniele Campa, Cosmeri Rizzato, et al. · Digestive and Liver Disease · 62
Triple approach strategy for patients with locally advanced pancreatic carcinoma
2012 · Alessandro Giardino, Roberto Girelli, et al. · HPB · 61
PDF
GemOx (Gemcitabine + Oxaliplatin) versus Gem (Gemcitabine) in non resectable pancreatic adenocarcinoma : final results of the GERCOR /GISCAD Intergroup Phase III
2004 · C. Louvet, R. Labianca, et al. · Journal of Clinical Oncology · 61
Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial
2016 · S. Lonardi, A. Sobrero, et al. · Annals of Oncology · 59
PDF
Chemotherapy in the last 30 days of life of advanced cancer patients
2015 · Paola Pacetti, Giovanni Paganini, et al. · Supportive Care in Cancer · 55
Intra-Arterial Hepatic Carboplatin-Based Chemotherapy for Ocular Melanoma Metastatic to the Liver. Report of a Phase II Study
1994 · Maurizio Cantore, Giammaria Fiorentini, et al. · Tumori Journal · 51
Association Between DNA-repair Polymorphisms and Survival in Pancreatic Cancer Patients Treated with Combination Chemotherapy
2011 · Elisa Giovannetti, Paola Pacetti, et al. · Pharmacogenomics · 49
AKT1 and SELP Polymorphisms Predict the Risk of Developing Cachexia in Pancreatic Cancer Patients
2014 · Abolfazl Avan, Amir Avan, et al. · PLoS ONE · 48
PDF
Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
2006 · Alfonso Del Freo, Giammaria Fiorentini, et al. · PubMed · 48
Irinotecan Hepatic Arterial Infusion Chemotherapy for Hepatic Metastases from Colorectal Cancer: A Phase II Clinical Study
2003 · Giammaria Fiorentini, Susanna Rossi, et al. · Tumori Journal · 48
Use and Perceived Benefits of Complementary Therapies by Cancer Patients Receiving Conventional Treatment in Italy
2013 · Andrea Bonacchi, Lorenzo Fazzi, et al. · Journal of Pain and Symptom Management · 43
PDF
Oxaliplatin hepatic arterial infusion chemotherapy for hepatic metastases from colorectal cancer: a phase I-II clinical study.
2004 · Giammaria Fiorentini, Susanna Rossi, et al. · PubMed · 42
TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects.
2008 · Giammaria Fiorentini, Camillo Aliberti, et al. · PubMed · 41
Intra-Arterial Hepatic Chemoembolization in Liver Metastases from Neuroendocrine Tumors: A Phase II Study
2004 · G. Fiorentini, S. Rossi, et al. · Journal of Chemotherapy · 38
Pharmacokinetics of Mitomycin C in Pelvic Stopflow Infusion and Hypoxic Pelvic Perfusion with and without Hemofiltration: A Pilot Study of Patients with Recurrent Unresectable Rectal Cancer
1998 · Stefano Guadagni, K. R. Aigner, et al. · The Journal of Clinical Pharmacology · 35
Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study.
2006 · Giammaria Fiorentini, Maurizio Cantore, et al. · PubMed · 34
Intra-arterial chemotherapy for unresectable pancreatic cancer
2000 · M. Cantore, P. Pederzoli, et al. · Annals of Oncology · 30
Works count: 172
Citation count: 2,451
H-index: 28
I10-index: 65
Year
Topic
Type